Article
Cancer omics: from regulatory networks to clinical outcomes.
Cancer letters - 1 Nov 2013
Tang Binhua, Hsu Pei-Yin, Huang Tim H-M, Jin Victor X
Abstract excerpt
Current limitation in cancer genomic studies is a lack of the integration of various omics data generated through next generation sequencing technologies, as well as a lack of the sounding and comprehensive epigenomic and genomic information about a particular cancer cell type. In this review, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
